Literature DB >> 15482014

Specific antibody response in a patient with Candida dubliniensis fungemia.

R Salesa1, M D Moragues, R Sota, J Pemán, G Quindós, J Pontón.   

Abstract

We report a case of fungemia caused by Candida dubliniensis in a non-HIV infected patient. Multiple cultures of blood performed over a period of 13 days were positive for this recently described yeast species. The C. dubliniensis isolates recovered were susceptible to fluconazole in vitro and the patient responded to intravenous therapy with this antifungal agent. It was possible to differentiate the fungemia caused by C. dubliniensis in this patient from that caused by C. albicans in other patients on the basis of the analysis of the antibody response since the C. dubliniensis-infected patient exhibited a characteristic and specific antibody response against a cell wall component of 160-170 kDa.

Entities:  

Year:  2001        PMID: 15482014

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  6 in total

1.  Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality.

Authors:  Rafael Zaragoza; Javier Pemán; Guillermo Quindós; Jose R Iruretagoyena; María S Cuétara; Paula Ramírez; Maria D Gómez; Juan J Camarena; Angel Viudes; José Pontón
Journal:  Clin Vaccine Immunol       Date:  2009-08-12

2.  Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.

Authors:  Sarah F Gee; Sophie Joly; David R Soll; Jacques F G M Meis; Paul E Verweij; Itzhack Polacheck; Derek J Sullivan; David C Coleman
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections.

Authors:  M D Moragues; M J Omaetxebarria; N Elguezabal; J Bikandi; G Quindós; D C Coleman; J Pontón
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans.

Authors:  Christian O Mosca; María D Moragues; José Llovo; Asmaa Al Mosaid; David C Coleman; José Pontón
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Susceptibility of Candida dubliniensis to salivary histatin 3.

Authors:  Deirdre H Fitzgerald; David C Coleman; Brian C O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.

Authors:  Javier Pemán; Rafael Zaragoza; Guillermo Quindós; Miriam Alkorta; María S Cuétara; Juan J Camarena; Paula Ramírez; María J Giménez; Estrella Martín-Mazuelos; María J Linares-Sicilia; José Pontón
Journal:  BMC Infect Dis       Date:  2011-03-09       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.